advertiser banner advertiser banner advertiser banner advertiser banner
Digital Issues

Home >  News >  August, 2013

Depuy Orthopaedics Recalls Lower Leg Implant

The FDA warns surgeons to immediately stop using the device.

Published: August 5, 2013

Depuy Orthopaedics has recalled the LPS Intercalary Dovetail Joint implant because the female end of the device could fracture after implantation when exposed to the normal physiologic loads of walking.

Depuy sent an urgent letter to distributors, hospitals and surgeons on July 11, asking them to immediately stop distributing or using the recalled lots. The FDA followed with a Class I recall on July 31, which lists the recalled lot numbers.

A Depuy spokeswoman says the implant is part of a system used to reconstruct severe soft tissue and bone defects in the thighbone. She explains that a portion of the implant has the potential to break, which could cause instability of the thighbone or pain, leading to a patient's inability to put weight on the operated leg. The company has received 7 complaints of device fracture after distributing approximately 96 implants in 8 countries from 2006 to 2013.

According to the spokeswoman, the risk of breakage increases in heavier patients, especially those weighing more than 200 lbs., and during activities such as walking and climbing stairs. The company isn't recommending replacement of the implant in the absence of symptoms, but surgeons are encouraged to communicate with patients who received the implant to discuss the risks of fracture and potential complications, which, says the FDA, include infection, loss of function, loss of limb, neurovascular injury or the need for revision surgery.

Daniel Cook


Also in the News...

Alabama Hospital Files Suit to Halt Construction of Competitor's ASC
Doris Parker, RN, Returns Today to Her Native Liberia to Help Curb Ebola
Participation High in Medicare's ASC Quality Reporting
Health Plan of Nevada Settles Hepatitis C Lawsuits
New Treatment for Obesity Relies on Embolization
Plastic Surgeon Accused of Writing Fake Prescriptions to Fuel His Addiction
Nurses Strike for Ebola Safety

 
Have an account? Please log in:
Email Address:
  Remember my login on this computer

DID YOU SEE THIS?
General Anesthesia

Less Costly, Less Invasive PONV Prevention

advertiser banner

Other Articles That May Interest You

FDA Initiates Second Compounding Pharmacy Recall This Week

Clinical Specialties Compounding Pharmacy's ophthalmic products at issue

Verathon Recalls Its Video Laryngoscope Reusable Blades

Fears of breakage and premature failure prompted the action.

Medtronic Xomed Recalling Endotracheal Tube

Some users experienced cuff deflation.